For over a quarter century, Dr. Aquila has been running a service that treats person with serious mental illness, predominately, schizophrenia. He serves as Medical Director of Fountain House. He has conducted numerous clinical trials. His team has been looking at other medical co-morbidities since the early nineties as a for the cause of premature death in persons with schizophrenia. Together with Fountain House is pushing forward the agenda about excess mortality in serious mental illness with the World Health Organization. He is an assistant professor of psychiatry at the Weil Cornell school of medicine, New York, New York.
To contact GME, email us at [email protected]